Acknowledging the kind of traction gained by this market, recently published a study report asserts the Lab Furniture market is expected to reach USD 2247.5 million by 2027, registering a phenomenal CAGR of 15.2% during the review period (2022 to 2027).
DNA methylation is definite as the progression of calculation or eliminating methyl group (-CH3) into DNA strand. This addition of the methyl group helps to alter or change the activity of the DNA segment without changing the sequence. Attendance of methyl group on gene promoter edge will repress gene transcription. DNA methylation process is used during gene editing, regulating tissue-specific gene appearance and X-chromosome inactivation.
The global DNA methylation market is segmented constructed on the product, application, technology, and end-user. By product, the market is segmented as enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. Enzymes are further sub-segmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Further, instruments and consumables are sub-segmented as next-generation sequencers, qPCR, mass spectrometers, so nicators, and others. Reagents are further sub-segmented as antibodies, buffers, histones, magnetic beads, primers, and others. By application, the market is segmented as oncology, metabolic diseases, progressive biology, immunology, cardiovascular diseases, and others. Based on application, the market is segmented as oncology, metabolic diseases, immunology, and others. Based on technology, the market is segregated as DNA methylation, histone modifications, and others. By end-user, the market is segmented as academic and research institutes, pharmaceutical, and biotechnology companies, and contract research establishments (CROs)
The Global DNA Methylation Market study report will provide a valuable insight with an emphasis on the global market including some of the major players such Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck Group, Pacific Biosciences of California, Inc., PerkinElmer, Inc., QIAGEN N.V., Thermo Fisher Scientific, Active Motif, Inc., Diagenode Diagnostics SA, EpiGentek Group Inc., New England Biolabs, Inc., Zymo Research Corporation
In January 2018: Thermo Fisher Scientific publicized an official agreement with Illumina to sell Ion Implies technology to researchers involved in conducting scientific studies on Illumina’s next-generation sequencing (NGS) platforms. This best-in-class amplification technology is highly effective in capturing DNA and RNA from minute amounts of samples for application in multiple areas of research. Further, under the agreement, Thermo Fisher will provide Illumina with Ion AmpliSeq technology for research use. Illumina will sell the product directly to its customers under the name AmpliSeq for Illumina.
In November 2019, PerkinElmer, Inc., publicized the launching of a new product namely, "NEXTFLEX® ChIP-Seq Kit". The newly launched product is used to accurately survey interactions between protein, DNA, and RNA enabling the explanation of regulation events central to many biological progressions and ailment states.
By Type, it is segmented into
By Application, it is segmented into
North America will take the lead in the global DNA methylation market in the coming years, with a sizable market share. One of the major factors driving the growth of the global DNA methylation market is the widespread use of technologically advanced facilities. Asia Pacific, on the other hand, is expected to grow the fastest during the forecast period due to rising disposable income, high unmet medical needs of the patient groups, rising awareness of early diagnosis, and availability of effective treatment options in emerging countries, particularly China and India, which stimulates the growth of the global DNA methylation market.
Report Attributes | Report Details |
Forecast Period 2022 to 2028 CAGR | CAGR of 15.2% during the review period (2022 to 2027). |
By Type |
|
By Application |
|
By Companies | Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck Group, Pacific Biosciences of California |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages |
138
|
Customization Available | Yes, the report can be customized as per your needs |
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
What is the study period of this market?
The DNA Methylation Market is studied from 2022-2027.
Who are the prime players in the DNA Methylation Market?
Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Illumina, Inc.
Which region held the largest share in the DNA Methylation Market?
United States, Europe, China, Japan, Southeast Asia, India and Rest of World
What are the significant types of DNA Methylation Market?
Consumables, Instruments, Software Tools
What are the major applications of DNA Methylation Market?
Pharmaceutical and Biotechnology Companies, Research and Academic Institutions, Contract Research Organizations (CROs), Others
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.